UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Targeting HOX and PBX transcription factors in ovarian cancer

BMC cancer, 2010-03, Vol.10 (1), p.89-89, Article 89

2010

Volltextzugriff (PDF)

Targeting the HOX/PBX dimer in breast cancer

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.389-398

2012

Volltextzugriff (PDF)

Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

Clinical cancer research, 2009-07, Vol.15 (13), p.4374-4381

2009

Volltextzugriff (PDF)

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

Clinical cancer research, 2008-11, Vol.14 (22), p.7358-7366

2008

Volltextzugriff (PDF)

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

BMC cancer, 2011-06, Vol.11 (1), p.221-221, Article 221

2011

Volltextzugriff (PDF)

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

Clinical cancer research, 2009-10, Vol.15 (19), p.6158-6166

2009

Volltextzugriff (PDF)

Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma

Cancer research (Chicago, Ill.), 2007-06, Vol.67 (12), p.5806-5813

2007

Volltextzugriff (PDF)

Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P

The Journal of urology, 2008-11, Vol.180 (5), p.2196-2201

2008

Volltextzugriff (PDF)

The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis

Molecular therapy, 2010-12, Vol.18 (12), p.2085-2093

2010

Volltextzugriff (PDF)

Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy

Clinical cancer research, 2008-08, Vol.14 (15), p.4915-4924

2008

Volltextzugriff (PDF)

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo

BMC cancer, 2010-09, Vol.10 (1), p.486-486, Article 486

2010

Volltextzugriff (PDF)

HOX transcription factors are potential targets and markers in malignant mesothelioma

BMC cancer, 2016-02, Vol.16 (87), p.85, Article 85

2016

Volltextzugriff (PDF)

Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair

Molecular therapy, 2010-09, Vol.18 (9), p.1599-1605

2010

Volltextzugriff (PDF)

Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (23), p.9771-9778

2008

Volltextzugriff (PDF)

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity

Cancer Immunology, Immunotherapy, 2004-04, Vol.53 (4), p.323-330

2004

Volltextzugriff (PDF)

Octreotide in malignant intestinal obstruction

Anti-cancer drugs, 1996-01, Vol.7 Suppl 1 (Supplement 1), p.5-10

1996

Volltextzugriff (PDF)

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Science translational medicine, 2018-01, Vol.10 (422)

2018

Volltextzugriff (PDF)

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Nature communications, 2021-03, Vol.12 (1), p.1930-1930, Article 1930

2021

Volltextzugriff (PDF)

Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy

Gene therapy, 2017-01, Vol.24 (1), p.21-30

2017

Volltextzugriff (PDF)

Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Science translational medicine, 2022-04, Vol.14 (640), p.eabn2231

2022

Volltextzugriff (PDF)

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

Molecular therapy, 2016-01, Vol.24 (1), p.166-174

2016

Volltextzugriff (PDF)

HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

BMC cancer, 2022-04, Vol.22 (1), p.400-13, Article 400

2022

Volltextzugriff (PDF)

The biology of the sodium iodide symporter and its potential for targeted gene delivery

Current cancer drug targets, 2010-03, Vol.10 (2), p.242-267

2010

Volltextzugriff (PDF)

Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence

Nature medicine, 2013-12, Vol.19 (12), p.1625-1631

2013

Volltextzugriff (PDF)

Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus

Clinical cancer research, 2008-01, Vol.14 (1), p.259-269

2008

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaMice

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Animals
(40)
Science & Technology
(39)
Life Sciences & Biomedicine
(38)
Humans
(25)
Oncology
(25)
Cell Line, Tumor
(22)
Melanoma
(18)
Tumors
(17)
Mice, Inbred C57bl
(16)
Cancer
(15)
Immunotherapy
(14)
Medicine, Research & Experimental
(14)
Research & Experimental Medicine
(14)
Biological And Medical Sciences
(12)
Viruses
(12)
Antigens
(11)
Biotechnology & Applied Microbiology
(10)
Medical Sciences
(10)
Oncolytic Virotherapy
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting HOX and PBX transcription factors in ovarian cancer

Targeting the HOX/PBX dimer in breast cancer

Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer

Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma

Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma

Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P

The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis

Radiation-Mediated Up-Regulation of Gene Expression from Replication-Defective Adenoviral Vectors: Implications for Sodium Iodide Symporter Gene Therapy

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo

HOX transcription factors are potential targets and markers in malignant mesothelioma

Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair

Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors

Heated tumour cells of autologous and allogeneic origin elicit anti-tumour immunity

Octreotide in malignant intestinal obstruction

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Oncolytic virotherapy induced CSDE1 neo-antigenesis restricts VSV replication but can be targeted by immunotherapy

Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy

Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses

HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

The biology of the sodium iodide symporter and its potential for targeted gene delivery

Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence

Cyclophosphamide Facilitates Antitumor Efficacy against Subcutaneous Tumors following Intravenous Delivery of Reovirus

Aktive Filter

Suchergebnisse filtern